• Fludarabine shortage requires flexibility, alternative approaches for CAR-T and HSCT

    4 days ago - By Healio

    For the second time in the last 2 years, a drug related to the administration of cellular therapy - fludarabine - has been placed on the FDA's drug shortage list.
    The FDA first noted the fludarabine shortage in May, with four of its manufacturers reporting either backordered or limited supplies available as of October.
    The FDA Drug Shortages website lists four manufacturers for the drug. Areva and Accord Healthcare provide no reason for the supply shortage, whereas Fresenius Kabi USA noted increased demand. Teva and Areva claim to have available supplies of fludarabine as of
    Read more ...